Syneron Candela updates on patent infringement cases

Syneron Candela today updated on a number of patent infringement suits, including a large number in defense of its Profound radiofrequency-based microneedling product. The Wayland, Mass-based company said that in April, it filed complaints against 18 manufacturers and distributors of fractional RF micro-needle dermatological treatment systems in both the U.S. Int’l Trade Commission and Federal District Court. Allegedly infringing products in the suit include the Secret RF by Ilooda and Cutera; Fraxis Duo by Ilooda, Emvera Tech and Rohrer Aesthetics; Fractora by Invasix and InMode MD; Legend Pro by Lumenis and Pollogen; 3DEEP by EndyMed Medical; INTRAcel by Jeisys Medical and Perigee Medical; Infini by Lutronic; and Vivace by Sung Hwan E&B, Aesthetics Biomedical and Cartessa Aesthetics, Syneron Candela said. In the suit with the ITC, Syneron Candela is seeking to block importation of all fractional RF micro-needle products into the US. The trial is scheduled for May 6, 2019, the company said. In an unrelated infringement case covering sublative tech patents, initiated in 2016 by Syneron Candela’s former owners against InMode and Invasix, the company said that the U.S. District Court for the Central District of California ruled that asserted claims were being held as invalid over prior art. The company said that it filed an appeal with the Court of Appeals for the Federal Circuit the day after the judgement was entered, and that it plans to “vigorously pu...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cosmetic/Aesthetic Legal News Patent Infringement Syneron Medical Ltd. Source Type: news